Published in Fertil Steril on November 01, 1998
Assessment of menopausal symptoms among women attending various outreach clinics in South Canara District of India. J Midlife Health (2014) 0.84
Factors that may influence the experience of hot flushes by healthy middle-aged women. J Womens Health (Larchmt) (2010) 0.83
Vasomotor symptoms in infertile premenopausal women: a hitherto unappreciated risk for low bone mineral density. Fertil Steril (2008) 0.83
Effects of Testosterone and Estradiol Deficiency on Vasomotor Symptoms in Hypogonadal Men. J Clin Endocrinol Metab (2016) 0.75
HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology (2010) 12.32
Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. Science (1999) 7.66
NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities. Mol Cell (1998) 7.58
Early treatment of acute biliary pancreatitis by endoscopic papillotomy. N Engl J Med (1993) 5.84
Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor. Science (2001) 5.25
Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3. EMBO J (2000) 5.22
Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg (1999) 4.97
A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex. Cell (1999) 4.65
Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg (2000) 4.44
Endoscopic biliary drainage for severe acute cholangitis. N Engl J Med (1992) 4.29
Identification and characterization of variable-number tandem repeats in the Yersinia pestis genome. J Clin Microbiol (2001) 4.08
Prospective randomized study of early versus delayed laparoscopic cholecystectomy for acute cholecystitis. Ann Surg (1998) 3.43
Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg (2001) 3.25
Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer (2000) 3.23
A prospective study on fish bone ingestion. Experience of 358 patients. Ann Surg (1990) 3.19
Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg (1999) 3.05
Hepatic resection for hepatocellular carcinoma. An audit of 343 patients. Ann Surg (1995) 3.04
Francisella tularensis strain typing using multiple-locus, variable-number tandem repeat analysis. J Clin Microbiol (2001) 2.99
A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor. Proc Natl Acad Sci U S A (1991) 2.93
Prospective evaluation of Pringle maneuver in hepatectomy for liver tumors by a randomized study. Ann Surg (1997) 2.83
Genetic locus in mice that blocks development of atherosclerosis despite extreme hyperlipidemia. Circ Res (2001) 2.55
Compliance with postoperative instructions: a telephone survey of 750 day surgery patients. Anaesthesia (2001) 2.53
Mismatch repair co-opted by hypermutation. Science (1998) 2.49
Hepatocellular carcinoma in the elderly: results of surgical and nonsurgical management. Am J Gastroenterol (1999) 2.47
Adult-to-adult living donor liver transplantation using extended right lobe grafts. Ann Surg (1997) 2.44
Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis. Arch Surg (1995) 2.37
alpha-synuclein promotes mitochondrial deficit and oxidative stress. Am J Pathol (2000) 2.36
Preoperative endoscopic drainage for malignant obstructive jaundice. Br J Surg (1994) 2.22
A human T lymphocyte differentiation marker defined by monoclonal antibodies that block E-rosette formation. J Immunol (1981) 2.20
HDAC3: taking the SMRT-N-CoRrect road to repression. Oncogene (2007) 2.19
Effects of the intermittent Pringle manoeuvre on hepatic gene expression and ultrastructure in a randomized clinical study. Br J Surg (2003) 2.19
Clinical implications of circulating angiogenic factors in cancer patients. J Clin Oncol (2001) 2.15
Antiretroviral resistance during successful therapy of HIV type 1 infection. Proc Natl Acad Sci U S A (2000) 2.13
Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial. J Thorac Cardiovasc Surg (1997) 2.09
Antiviral therapy improves post-hepatectomy survival in patients with hepatitis B virus-related hepatocellular carcinoma: a prospective-retrospective study. Aliment Pharmacol Ther (2014) 2.06
Familial colorectal cancer risk by subsite of primary cancer: a population-based study in Utah. Aliment Pharmacol Ther (2015) 2.03
Distribution and molecular analysis of Lyme disease spirochetes, Borrelia burgdorferi, isolated from ticks throughout California. J Clin Microbiol (1993) 2.03
Significance of resection margin in hepatectomy for hepatocellular carcinoma: A critical reappraisal. Ann Surg (2000) 2.01
Cilia with defective radial spokes: a cause of human respiratory disease. N Engl J Med (1979) 2.01
A prospective study of operative risk factors in perforated duodenal ulcers. Ann Surg (1982) 2.00
Two cases of acrometastasis to the hands and review of the literature. Curr Oncol (2008) 2.00
The Shatin community mental health survey in Hong Kong. II. Major findings. Arch Gen Psychiatry (1993) 1.99
Hepatectomy with an ultrasonic dissector for hepatocellular carcinoma. Br J Surg (1996) 1.97
Analysis of reduced death and complication rates after esophageal resection. Ann Surg (2001) 1.96
Adaptive radiation therapy. Phys Med Biol (1997) 1.94
Management of spontaneous rupture of hepatocellular carcinoma: single-center experience. J Clin Oncol (2001) 1.93
Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma. N Engl J Med (1994) 1.93
Early versus delayed laparoscopic cholecystectomy for treatment of acute cholecystitis. Ann Surg (1996) 1.92
Risk factors for perioperative morbidity and mortality after extended hepatectomy for hepatocellular carcinoma. Br J Surg (2003) 1.88
Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. Br J Surg (1997) 1.86
Anterior approach for major right hepatic resection for large hepatocellular carcinoma. Ann Surg (2000) 1.83
Activation of p38 mitogen-activated protein kinase and c-Jun NH(2)-terminal kinase by double-stranded RNA and encephalomyocarditis virus: involvement of RNase L, protein kinase R, and alternative pathways. Mol Cell Biol (2000) 1.83
Premenstrual syndrome. Am J Obstet Gynecol (1981) 1.80
Early results with partial left ventriculectomy. J Thorac Cardiovasc Surg (1997) 1.78
Time-Resolved X-ray Diffraction Study of Solid Combustion Reactions. Science (1990) 1.76
Canadian experience with the pipeline embolization device for repair of unruptured intracranial aneurysms. AJNR Am J Neuroradiol (2012) 1.74
Treatment of advanced hepatocellular carcinoma with tamoxifen and the correlation with expression of hormone receptors: a prospective randomized study. Am J Gastroenterol (2000) 1.73
HIV-1-specific cytotoxic T lymphocyte responses in the first year of life. J Immunol (1995) 1.69
Hepatectomy for hepatocellular carcinoma: the surgeon's role in long-term survival. Arch Surg (1999) 1.68
An initial appraisal of the clinical significance of Roseomonas species associated with human infections. Clin Infect Dis (1996) 1.67
Comparison of maximal acid output and gastrin response to meals in Chinese and Scottish normal and duodenal ulcer subjects. Gut (1980) 1.67
p300 requires its histone acetyltransferase activity and SRC-1 interaction domain to facilitate thyroid hormone receptor activation in chromatin. Mol Cell Biol (2000) 1.66
The surgical management of primary carcinoma of the liver. World J Surg (1982) 1.64
The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C. J Immunol (1997) 1.63
Biliary complications after hepatic resection: risk factors, management, and outcome. Arch Surg (1998) 1.63
Right lobe living donor liver transplantation with or without venovenous bypass. Br J Surg (2003) 1.63
Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence. J Surg Oncol (2000) 1.62
Beta-Lactamase activity in strains of Bacteroides melaninogenicus and Bacteroides oralis. Antimicrob Agents Chemother (1977) 1.62
Laser in situ keratomileusis: literature review of a developing technique. J Cataract Refract Surg (1998) 1.61
A prospective randomized comparison of transhiatal and transthoracic resection for lower-third esophageal carcinoma. Am J Surg (1997) 1.61
Structural basis for Syk tyrosine kinase ubiquity in signal transduction pathways revealed by the crystal structure of its regulatory SH2 domains bound to a dually phosphorylated ITAM peptide. J Mol Biol (1998) 1.60
Identification of differentially expressed genes in esophageal squamous cell carcinoma (ESCC) by cDNA expression array: overexpression of Fra-1, Neogenin, Id-1, and CDC25B genes in ESCC. Clin Cancer Res (2001) 1.60
Thoracoscopic esophagectomy for esophageal cancer. Surgery (1997) 1.60
Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia. Mol Psychiatry (2012) 1.58
Selective coating of gastric ulcer by tripotassium dicitrato bismuthate in the rat. Gastroenterology (1982) 1.58
Comparison of hand-sewn and stapled esophagogastric anastomosis after esophageal resection for cancer: a prospective randomized controlled trial. Ann Surg (1997) 1.58
Placental transforming growth factor-beta is a downstream mediator of the growth arrest and apoptotic response of tumor cells to DNA damage and p53 overexpression. J Biol Chem (2000) 1.58
Pickled vegetables in the aetiology of oesophageal cancer in Hong Kong Chinese. Lancet (1992) 1.56
Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma. Br J Surg (2007) 1.56
Results of partial left ventriculectomy for dilated cardiomyopathy: hemodynamic, clinical and echocardiographic observations. J Am Coll Cardiol (2000) 1.55
Postoperative adjuvant chemotherapy after curative resection of hepatocellular carcinoma: a randomized controlled trial. Arch Surg (1998) 1.54
Pattern of recurrence after oesophageal resection for cancer: clinical implications. Br J Surg (1996) 1.53
Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma: a prospective study. Ann Surg (2001) 1.52
Postoperative radiotherapy for carcinoma of the esophagus: a prospective, randomized controlled study. Surgery (1993) 1.47
Recurrent pyogenic cholangitis: current management. World J Surg (1991) 1.46
Esophagectomy for carcinoma of the esophagus in the elderly: results of current surgical management. Ann Surg (1998) 1.45
Pituitary apoplexy. A review. Arch Neurol (1985) 1.44
Are men shortchanged on health? Perspective on health care utilization and health risk behavior in men and women in the United States. Int J Clin Pract (2010) 1.44
Molecular determinants of apoptosis induced by the cytotoxic ribonuclease onconase: evidence for cytotoxic mechanisms different from inhibition of protein synthesis. Cancer Res (2000) 1.43
Randomized clinical trial of open hepatectomy with or without intermittent Pringle manoeuvre. Br J Surg (2012) 1.43
Extended hepatectomy for hepatocellular carcinoma. Br J Surg (1990) 1.43
Esophagogastric anastomosis performed with a stapler: the occurrence of leakage and stricture. Surgery (1987) 1.41
Clinicopathologic features of long-term survivors and disease-free survivors after resection of hepatocellular carcinoma: a study of a prospective cohort. J Clin Oncol (2001) 1.41
The Wilms tumor suppressor WT1 encodes a transcriptional activator of amphiregulin. Cell (1999) 1.40
Invasion of reconstituted basement membrane matrix by metastatic human tumor cells. Cancer Res (1986) 1.39
p130 is dispensable in peripheral T lymphocytes: evidence for functional compensation by p107 and pRB. Mol Cell Biol (1998) 1.39
Increased incidence of Clostridium difficile infection. J Hosp Infect (1997) 1.39
Minimum graft size for successful living donor liver transplantation. Transplantation (1999) 1.39
Perforated duodenal ulcers. World J Surg (1987) 1.38